Articles

HemoShear creates systems for predicting human responses to drugs by applying its proprietary technology
to human cells in the lab to make them behave the way they would in vivo. LSIPR found out about its strategy for protecting and developing its technologies.

The development of gene technologies is still at a relatively early stage, with patent applications coming from research institutes and universities as well as industry. Gareth Williams has crunched the numbers.